DRKS00022943已完成不适用
Prospective Observational Post-Authorisation Study on Fresh-transfer and Freeze-all treatments of ART patients undergoing controlled ovarian stimulation with Follitropin alfa (Bemfola®) - FREEZE-A
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 956
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18 Years 至 60 Years（—）
- 性别
- Female
入选标准
- •Eligible patients must meet the following criteria:
- •- Adult female patient with an indication for IVF/ICSI treatment
- •- Planned first ART stimulation cycle
- •- Planned to receive Bemfola® as monotherapy for ovarian stimulation
- •- Signed Informed Patient Consent form (ICF)
排除标准
- •Eligible patients must not meet the following criteria:
- •- History of previous poor response to gonadotropins outside ART
- •- Planned Fertility Protection (due to malignancies etc.)
- •- Ovarian Random Start and Duo Stimulations
- •- Serum AMH-Level < 1,0 ng/ml
研究者
相似试验
尚未招募
Unknown
Study on the Effectiveness and Safety of Once-Daily Brivaracetam for Drug-Resistant Focal Onset EpilepsyCTRI/2024/07/070210Torrent Pharmaceuticals Ltd
尚未招募
不适用
Study to check the safety and effectiveness of Sitagliptin and Dapagliflozin combination in Type 2 Diabetes patients with heart problemsCTRI/2022/09/045218Torrent Pharmaceuticals Ltd
尚未招募
4 期
To assess safety and effectiveness of Sitagliptin, Glimepiride, and Metformin for diabetes patients in India.CTRI/2024/03/064004Torrent Pharmaceuticals Ltd
尚未招募
4 期
Study to check the result and safety of combination treatment of vildagliptin and dapagliflozin in type 2 diabetes mellitus patientCTRI/2022/08/044757Torrent Pharmaceuticals Ltd
尚未招募
不适用
Study to check the safety and benefits of medicine Bisoprolol in Heart disease patientsCTRI/2023/01/049287Torrent Pharmaceuticals Ltd